Pune, Maharashtra -- (SBWire) -- 05/28/2019 --According to a recent report by Fact.MR, the global lung cancer diagnostics market is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.
Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies. Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=49
Several awareness programs related to lung cancer and its symptoms are being taken by the private as well as government authorities for enhancing the diagnosis as well as screening rates of patients with high risks of lung malignancies. In the United Kingdom, November has been considered as lung cancer awareness month, and Roy Castle Lung Cancer Foundation has been supporting the initiative. These kinds of initiatives will fuel demand for diagnosis of lung cancer, which in turn will propel growth of the market.
10 Key Takeaways from Fact.MR's Report on the Global Lung Cancer Diagnostics Market
North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.
Browse Full Report @ https://www.factmr.com/report/49/lung-cancer-diagnostics-market
Key market players included in Fact.MR's report are Illumina, Inc., Thermo Fischer Scientific, Inc., Quest Diagnostics Incorporated, NanoString Technologies, Inc., Myriad Genetics, Inc., Roche Holding AG, Abbott Laboratories, QIAGEN N.V., NeoGenomics Laboratories, Inc., and Danaher Corporation.
To deliver a seamless understanding of the Lung Cancer Diagnostics market, the report is divided into 18 sophisticated chapters whose snapshots are provided below.
Chapter 1 – Executive Summary
The report commences with the chapter of the executive summary which delivers brief yet affluent information of the Lung Cancer Diagnostics market. The chapter includes discussion on the market overview, market analysis and market recommendations regarding the Lung Cancer Diagnostics market derived based on Fact.MR's proprietary wheel of fortune.
Chapter 2 – Market Introduction
In the market introduction chapter, the Lung Cancer Diagnostics market is introduced along with the
market segmentation in the form of market taxonomy. The chapter also introduces the Lung Cancer Diagnostics in the market definition section.
Chapter 3 - Lung Cancer Diagnostics Market Background
In this chapter, macroeconomic factors, market dynamics, a complete value chain and pricing
analysis with regard to Lung Cancer Diagnostics market is elaborately discussed. Discussion on the
market drivers, restraints, trends and opportunities and their impact on the market forecast is also
covered in this chapter.
You can Buy This Report from Here @ https://www.factmr.com/checkout/49/S
Chapter 4 - Global Lung Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides the Lung Cancer Diagnostics market size in terms of market volume and value
during the forecast period. Market analysis based on absolute $ opportunity and y-o-y growth of the Lung Cancer Diagnostics market is also covered in this chapter.
Chapter 5 - Global Lung Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026,
By System Type Based on system types in the Lung Cancer Diagnostics market, the chapter elaborates market size of individual systems and analysis by system types and summary of this section is covered in the chapter.
Chapter 6 - Global Lung Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026, By Application
Based on applications, Market size of individual applications, their market attractiveness analysis and summary are also covered.
Chapter 7 - Global Lung Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026, By End User
This chapter elaborates the segmentation of the Lung Cancer Diagnostics market based on end users
including independent end users, Market attractive analysis by end users is also discussed to fathom relative lucrativeness of different end users of the Lung Cancer Diagnostics market.
Chapter 8 - Global Lung Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026, By Region
With the geographical perspective, the Lung Cancer Diagnostics market is analyzed on a total of seven regions including North America, Latin America, Europe, South East Asia & Pacific, Middle East & Africa, China and Japan. Historical data and prevailing trends in the Lung Cancer Diagnostics market and their influence on the global market performance is discussed in this chapter.
And Continue....
Lung Cancer Diagnostics Market: Analysis and in-Depth Study on Market Size Trends, Emerging Growth Factors and Forecasts to 2023
Fact.MR has announced the addition of the “ Lung Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.